Literature DB >> 11139583

Covalently linked heme in cytochrome p4504a fatty acid hydroxylases.

U Hoch1, P R Ortiz De Montellano.   

Abstract

Three independent experimental methods, liquid chromatography, denaturing gel electrophoresis with heme staining, and mass spectrometry, establish that the CYP4A class of enzymes has a covalently bound heme group even though the heme is not cross-linked to the protein in other P450 enzymes. Covalent binding has been demonstrated for CYP4A1, -4A2, -4A3, -4A8, and -4A11 heterologously expressed in Escherichia coli. However, the covalent link is also present in CYP4A1 isolated from rat liver and is not an artifact of heterologous expression. The extent of heme covalent binding in the proteins as isolated varies and is substoichiometric. In CYP4A3, the heme is attached to the protein via an ester link to glutamic acid residue 318, which is on the I-helix, and is predicted to be within the active site. This is the first demonstration that a class of cytochrome P450 enzymes covalently binds their prosthetic heme group.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11139583     DOI: 10.1074/jbc.M009969200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  17 in total

Review 1.  Structural control of cytochrome P450-catalyzed ω-hydroxylation.

Authors:  Jonathan B Johnston; Hugues Ouellet; Larissa M Podust; Paul R Ortiz de Montellano
Journal:  Arch Biochem Biophys       Date:  2010-08-19       Impact factor: 4.013

2.  Heme and I.

Authors:  Paul R Ortiz de Montellano
Journal:  J Biol Chem       Date:  2015-07-20       Impact factor: 5.157

3.  Heme-thiolate sulfenylation of human cytochrome P450 4A11 functions as a redox switch for catalytic inhibition.

Authors:  Matthew E Albertolle; Donghak Kim; Leslie D Nagy; Chul-Ho Yun; Ambra Pozzi; Üzen Savas; Eric F Johnson; F Peter Guengerich
Journal:  J Biol Chem       Date:  2017-05-22       Impact factor: 5.157

4.  Functional expression and characterization of cytochrome P450 52A21 from Candida albicans.

Authors:  Donghak Kim; Max J Cryle; James J De Voss; Paul R Ortiz de Montellano
Journal:  Arch Biochem Biophys       Date:  2007-03-16       Impact factor: 4.013

5.  Metabolism of Benzalkonium Chlorides by Human Hepatic Cytochromes P450.

Authors:  Ryan P Seguin; Josi M Herron; Vanessa A Lopez; Joseph L Dempsey; Libin Xu
Journal:  Chem Res Toxicol       Date:  2019-12-03       Impact factor: 3.739

6.  Glutamine-451 Confers Sensitivity to Oxidative Inhibition and Heme-Thiolate Sulfenylation of Cytochrome P450 4B1.

Authors:  Matthew E Albertolle; Hyun D Song; Clayton J Wilkey; Jere P Segrest; F Peter Guengerich
Journal:  Chem Res Toxicol       Date:  2019-02-11       Impact factor: 3.739

Review 7.  CYP4 enzymes as potential drug targets: focus on enzyme multiplicity, inducers and inhibitors, and therapeutic modulation of 20-hydroxyeicosatetraenoic acid (20-HETE) synthase and fatty acid ω-hydroxylase activities.

Authors:  Katheryne Z Edson; Allan E Rettie
Journal:  Curr Top Med Chem       Date:  2013       Impact factor: 3.295

8.  Mechanism of formation of the ester linkage between heme and Glu310 of CYP4B1: 18O protein labeling studies.

Authors:  Brian R Baer; Kent L Kunze; Allan E Rettie
Journal:  Biochemistry       Date:  2007-09-19       Impact factor: 3.162

9.  Covalent heme attachment to the protein in human heme oxygenase-1 with selenocysteine replacing the His25 proximal iron ligand.

Authors:  Yongying Jiang; Michael J Trnka; Katalin F Medzihradszky; Hugues Ouellet; Yongqiang Wang; Paul R Ortiz de Montellano
Journal:  J Inorg Biochem       Date:  2008-11-19       Impact factor: 4.155

10.  Role of the highly conserved threonine in cytochrome P450 2E1: prevention of H2O2-induced inactivation during electron transfer.

Authors:  Yasushi Yoshigae; Ute M Kent; Paul F Hollenberg
Journal:  Biochemistry       Date:  2013-06-28       Impact factor: 3.162

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.